Valuation: Yixintang Pharmaceutical Group Co., Ltd.

Market Cap 7.52B 1.13B 1.01B 933M 844M 1.58B 107B 1.61B 11.22B 4.44B 56.09B 4.23B 4.14B 178B P/E 2026 *
16.7x
P/E 2027 * 14x
Enterprise Value 6.28B 942M 842M 779M 705M 1.32B 89.58B 1.34B 9.37B 3.71B 46.85B 3.53B 3.46B 148B EV / Sales 2026 *
0.36x
EV / Sales 2027 * 0.33x
Free-Float
51.88%
Yield 2026 *
2.75%
Yield 2027 * 3.76%
1 day+3.23%
1 week+0.92%
Current month+22.20%
1 month+23.58%
3 months+19.63%
6 months+4.47%
Current year+1.87%
1 week 12.57
Extreme 12.57
13.42
1 month 10.59
Extreme 10.59
13.42
Current year 9.41
Extreme 9.41
14.8
1 year 9.41
Extreme 9.41
14.8
3 years 9.41
Extreme 9.41
26.45
5 years 9.41
Extreme 9.41
41.55
10 years 9.41
Extreme 9.41
50.1
Manager TitleAgeSince
Chief Executive Officer 48 22/11/2023
President 60 25/11/2019
Director of Finance/CFO 44 22/11/2023
Director TitleAgeSince
Chairman 60 01/06/2009
Chairman 61 01/06/2009
Director/Board Member 44 16/11/2016
Date Insider Type Main position Quantity % Market Cap. Importance
12/5/26 Buy

Founder

1,359,000 0.3397%
12/5/26 Sell

Founder

-2,727,600 0.6818%
11/5/26 Sell

Founder

-8,806,300 2.2012%
Change 5-day change 1-year change 3-year change Capi.($)
+3.23%+0.92%-5.55%-37.74% 1.09B
+0.16%-2.33%-39.74%+11.59% 15.29B
-14.39%-23.59%-18.16%-38.15% 7.04B
+1.26%+4.40%-8.01%+2.79% 6.58B
+1.10%+1.99%-15.22%+5.63% 6.44B
-0.70%-5.32%-51.94%-35.34% 5.91B
+0.67%+1.79%+1.27%-1.49% 4.61B
+0.49%-1.19%-14.41%-13.86% 3.21B
+4.63%+2.10%+1.71%-17.03% 3.1B
-6.97%-9.76%-42.31%-12.25% 3.02B
Average -1.05%-1.33%-19.24%-13.59% 5.63B
Weighted average by Cap. -1.53%-1.38%-24.20%-7.60%

Financials

2026 *2027 *
Net sales 17.57B 2.63B 2.35B 2.18B 1.97B 3.69B 251B 3.75B 26.22B 10.37B 131B 9.88B 9.67B 415B 18.59B 2.79B 2.49B 2.3B 2.09B 3.91B 265B 3.97B 27.73B 10.97B 139B 10.45B 10.23B 439B
Net income 456M 68.37M 61.14M 56.56M 51.21M 95.85M 6.5B 97.42M 681M 269M 3.4B 257M 251M 10.77B 547M 81.94M 73.27M 67.79M 61.38M 115M 7.8B 117M 816M 323M 4.08B 308M 301M 12.91B
Net Debt -1.24B -186M -166M -154M -139M -260M -17.66B -265M -1.85B -731M -9.24B -697M -682M -29.25B -1.42B -213M -191M -177M -160M -299M -20.3B -304M -2.12B -840M -10.62B -801M -784M -33.62B
Projected Income Statement - Annual - Yixintang Pharmaceutical Group Co., Ltd.
Logo Yixintang Pharmaceutical Group Co., Ltd.
Yixintang Pharmaceutical Co Ltd, formerly Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical retail chains. The Company is also engaged in major health industries such as pharmaceutical distribution, traditional Chinese medicine industry, medical business, convenience goods, personal care and beauty. The Company's main products include regular decoction pieces, direct oral decoction pieces, active ingredients, ultrafine powders, toxic decoction pieces, and formula granules. The Company mainly operates five major brands: Hongxiang, Shanshang, Huipin, Bendian and Hanzun. The Company mainly operates its businesses in the domestic market.
Employees
34,848
Date Price Change Volume
26/10/26 CNY 13.10 +3.23% 16,585,940
23/10/26 CNY 12.69 -2.16% 14,880,243
22/10/26 CNY 12.97 -2.11% 15,543,072
21/10/26 CNY 13.25 +1.30% 15,653,930
20/10/26 CNY 13.08 -1.21% 21,657,600
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Yixintang Pharmaceutical Group Co., Ltd.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
13.10CNY
Average target price
13.19CNY
Spread / Average Target
+0.69%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Yixintang Pharmaceutical Group Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 002727 Stock